US Broker Ratings

Chevron Corporation (CVX) Stock Analysis: Exploring a 9.51% Potential Upside Amidst Market Volatility

Chevron Corporation (NYSE: CVX), a titan in the energy sector with a market capitalization of $310.64 billion, remains a compelling choice for investors seeking stability and..

SANUWAVE Health, Inc. (SNWV) Stock Analysis: A Promising 39% Upside in a Rapidly Growing Medical Device Sector

SANUWAVE Health, Inc. (NASDAQ: SNWV), a key player in the healthcare sector, specifically within the medical devices industry, is making waves with its innovative approach to..

Rigel Pharmaceuticals, Inc. (RIGL) Stock Analysis: Unpacking the 23.56% Potential Upside

For investors eyeing the biotechnology sector, Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) represents an intriguing prospect, boasting a compelling 23.56% potential upside according to recent analyst ratings...

Aura Biosciences, Inc. (AURA) Stock Analysis: Exploring a 214% Upside Potential on Innovative Cancer Therapies

Aura Biosciences, Inc. (NASDAQ: AURA), a prominent player in the biotechnology sector, is capturing significant attention from investors, thanks to its groundbreaking approach to cancer treatment..

iTeos Therapeutics, Inc. (ITOS) Stock Analysis: Exploring a 5.22% Upside Amid Biotech Innovation

For investors with an eye on the biotechnology sector, iTeos Therapeutics, Inc. (NASDAQ: ITOS) presents an intriguing opportunity. With its current market capitalization of $446.57 million,..

Pacific Biosciences of California (PACB) Stock Analysis: Is a 48.91% Upside on the Horizon?

Pacific Biosciences of California, Inc. (NASDAQ: PACB), a prominent player in the medical devices industry within the healthcare sector, is garnering attention with a potential upside..

Alumis Inc. (ALMS) Investor Outlook: Exploring a Potential 367% Upside in Biotech Innovation

For investors eyeing the healthcare sector, particularly the volatile yet promising biotechnology industry, Alumis Inc. (NASDAQ: ALMS) presents a tantalizing opportunity. The clinical-stage biopharmaceutical company, headquartered..

XOMA Royalty Corporation (XOMA): Investor Outlook with a 144.76% Potential Upside

XOMA Royalty Corporation (NASDAQ: XOMA), a biotech royalty aggregator, has captured investor attention with a substantial market cap of $316.17 million and a remarkable potential upside..

Spok Holdings, Inc. (SPOK) Stock Analysis: A Promising 14.32% Upside in the Healthcare Communication Sector

Spok Holdings, Inc. (NASDAQ: SPOK), a key player in the healthcare communication solutions arena, holds notable promise for investors seeking opportunities within the healthcare sector. With..

Alpha Teknova, Inc. (TKNO): Investor Outlook Highlights a Promising 129.89% Upside Potential

Alpha Teknova, Inc. (NASDAQ: TKNO), a key player in the healthcare sector specializing in drug manufacturing, is capturing investor attention with a potential upside of 129.89%...

NANO-X IMAGING LTD (NNOX) Stock Analysis: Exploring the 86% Potential Upside in the Medical Devices Sector

Nano-X Imaging Ltd. (NASDAQ: NNOX), an innovative player in the healthcare sector, is making waves in the medical devices industry with its cutting-edge tomographic imaging technology...

TruBridge, Inc. (TBRG) Investor Outlook: Analyzing a 37% Potential Upside in the Healthcare Information Sector

TruBridge, Inc. (NASDAQ: TBRG), a key player in the healthcare information services industry, has captured the attention of investors with a notable potential upside of 37.13%...

Fulcrum Therapeutics, Inc. (FULC) Investor Outlook: Exploring a 59.53% Potential Upside in Biotech

Fulcrum Therapeutics, Inc. (NASDAQ: FULC), a clinical-stage biopharmaceutical company, is making waves in the healthcare sector with its innovative approach to tackling genetically defined diseases. With..

Zhengye Biotechnology Holding L (ZYBT) Stock Analysis: Navigating a Challenging Market with Strategic Innovation

Zhengye Biotechnology Holding Limited (ZYBT), a key player in the healthcare sector specializing in the development and sale of veterinary vaccines, presents a complex yet intriguing..

Absci Corporation (ABSI) Stock Analysis: A Biotech with 211% Upside Potential

Absci Corporation (NASDAQ: ABSI) is emerging as a compelling player in the biotechnology sector, offering investors a unique entry point into the burgeoning field of AI-driven..

10x Genomics, Inc. (TXG): Investor Outlook and Valuation Insights Amidst a Transformative Healthcare Landscape

10x Genomics, Inc. (NASDAQ: TXG), a vanguard in the healthcare sector’s health information services industry, is maneuvering through a complex yet promising landscape. With a market..

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: Exploring a 53% Potential Upside

Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) presents an intriguing opportunity for investors eyeing the healthcare sector, particularly in the medical care facilities industry. This Atlanta-based company,..

MiMedx Group, Inc. (MDXG) Stock Analysis: Unveiling a 70% Potential Upside for Bold Investors

MiMedx Group, Inc. (MDXG) stands at the crossroads of innovation and opportunity within the biotechnology sector, positioning itself as a compelling prospect for investors with a..

89bio, Inc. (ETNB) Investor Outlook: Analyzing the 215% Potential Upside in Biotech

In the ever-evolving landscape of biotechnology, 89bio, Inc. (ETNB) emerges as a significant player, captivating investor interest with a staggering potential upside of 215.36%. With its..

Omnicell, Inc. (OMCL) Investor Outlook: Exploring a 45.74% Potential Upside

Omnicell, Inc. (NASDAQ: OMCL), a key player in the healthcare sector, specializes in providing innovative medication management solutions and adherence tools to healthcare systems and pharmacies...

US Broker Ratings

US Broker Ratings

FTSE 100

Funds